<DOC>
	<DOCNO>NCT00994149</DOCNO>
	<brief_summary>Diazoxide oral hyperglycemic medication . Diazoxide proven effective treat hypoglycemia infant child type persistent hyperinsulinemic hypoglycemia . The mechanism action result decrease insulin secretion . One cause hypoglycemia infant diabetic mother occurs due transient hyperinsulinemic state postnatally . The investigator clinical experience success use diazoxide unit patient hypoglycemia adequately manage intravenous ( iv ) dextrose enteral supplementation . In randomize control study investigator expect use diazoxide initial treatment infant diabetic mother asymptomatic hypoglycemia ( blood glucose 2.5 2.0mmol/L ) , investigator able decrease number infant require intravenous least thirty percent .</brief_summary>
	<brief_title>Diazoxide In Management Of Hypoglycemic Neonates</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Infant , Newborn , Diseases</mesh_term>
	<mesh_term>Fetal Macrosomia</mesh_term>
	<mesh_term>Pregnancy Diabetics</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>Infants diabetic mother ( IDMs ) infant weigh &gt; 90 % Hypoglycemia : two consecutive blood glucose measurement &lt; 2.6mol/L &gt; 1.9mmol/L first twelve hour life &gt; 36 week gestational age Infants symptomatic hypoglycemia ( regardless value Infants meet criterion intravenous dextrose accord Canadian Pediatric Society ( CPS ) position statement Infants contraindications enteral feed and/or medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Hours</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Infants Diabetic Mothers</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Diazoxide</keyword>
	<keyword>Large Gestation Infants</keyword>
</DOC>